RBR-7wvr64k
Recruiting
Phase 1
Evaluation of the prophilatic effects of the flavonoid Hesperidin Methyl Chalcone on Delayed Onset Muscle Soreness in humans
niversidade Norte do Paraná0 sitesAugust 16, 2022
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Myalgia
- Sponsor
- niversidade Norte do Paraná
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male; age between 18 and 45 years old; and to be able to develop the proposed exercise\-induced muscle pain model.
Exclusion Criteria
- •Musculoskeletal and/or neurological lower limby injuries diagnosed at the time of screening; chronic use of anti\-inflammatory, antidepressant and/or analgesic drugs will be considered an exclusion factor (considering that they may interfere in the analysis of some parameters that will be evaluated in the study, such as muscle pain and production of cytokines and other biological markers); calorie\-restricted diet; and ergogenic supplementation.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder.EUCTR2006-003658-47-FRPierre Fabre Médicament - IRPF180
Completed
Phase 1
Evaluation of the effectiveness of Q-Switched ND:YAG laser in the treatment of facial skin lesionsEye dark circles.-IRCT20080901001159N31Tehran University of Medical Sciences37
Not yet recruiting
Phase 3
Comparative study of the efficacy and safety of FormoterolCTRI/2017/03/008277Rus Biopharm LLC136
Not yet recruiting
Phase 2
Investigating the effect of the active form of fulate on homocysteineIRCT20240722062513N1Tehran University of Medical Sciences50
Recruiting
Phase 2
A observational study for safety and efficacy of Fulvestrant 500mg in postmenopausal patients with ER positive advanced or recurrent breast cancer after prior endocrine treatment. (SBCCSG-29)ocally advanced or metastatic breast cancerJPRN-UMIN000009110Saitama Breast Cancer Clinical Study Group(SBCCSG)100